Key statistics
On Friday, Pulse Biosciences Inc (6L8:FRA) closed at 16.70, -14.36% below its 52-week high of 19.50, set on Aug 22, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 16.70 |
---|---|
High | 16.70 |
Low | 16.70 |
Bid | 15.90 |
Offer | 16.20 |
Previous close | 17.40 |
Average volume | 40.00 |
---|---|
Shares outstanding | 61.29m |
Free float | 17.04m |
P/E (TTM) | -- |
Market cap | 1.10bn USD |
EPS (TTM) | -0.7916 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 07:21 BST.
More ▼
Press releases
- Pulse Biosciences Reports Business Updates and Preliminary Second Quarter 2024 Financial Results
- Pulse Biosciences, Inc. Appoints Paul LaViolette to Its Board of Directors
- Pulse Biosciences, Inc. Announces Successful Treatment of Patients in First-in-Human Study with its Nano-PFA Cardiac Surgery System
- Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences
- Pulse Biosciences Schedules Second Quarter 2024 Financial Results Conference Call for August 12, 2024
- Pulse Biosciences, Inc. Announces Receipt of FDA Breakthrough Device Designation for CellFX® nsPFA Cardiac Surgery System for the Treatment of Atrial Fibrillation
- Pulse Biosciences, Inc. Announces the Closing of its Rights Offering
- Pulse Biosciences, Inc. Announces Preliminary Results for its Rights Offering
More ▼